WO2014167582A3 - Composition de vaccin contre la prophylaxie chez des ruminants - Google Patents

Composition de vaccin contre la prophylaxie chez des ruminants Download PDF

Info

Publication number
WO2014167582A3
WO2014167582A3 PCT/IN2014/000204 IN2014000204W WO2014167582A3 WO 2014167582 A3 WO2014167582 A3 WO 2014167582A3 IN 2014000204 W IN2014000204 W IN 2014000204W WO 2014167582 A3 WO2014167582 A3 WO 2014167582A3
Authority
WO
WIPO (PCT)
Prior art keywords
bluetongue
ruminants
prophylaxis
vaccine composition
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2014/000204
Other languages
English (en)
Other versions
WO2014167582A2 (fr
Inventor
Pavuluri Panduranga RAO
Nagendra Ramachandra HEGDE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ELLA FOUNDATION
Original Assignee
ELLA FOUNDATION
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ELLA FOUNDATION filed Critical ELLA FOUNDATION
Publication of WO2014167582A2 publication Critical patent/WO2014167582A2/fr
Publication of WO2014167582A3 publication Critical patent/WO2014167582A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12111—Orbivirus, e.g. bluetongue virus
    • C12N2720/12134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12111—Orbivirus, e.g. bluetongue virus
    • C12N2720/12161—Methods of inactivation or attenuation
    • C12N2720/12163—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des compositions de vaccin contre le sérotype 12 de la fièvre catarrhale du mouton, et une préparation de vaccin contre la fièvre catarrhale du mouton dans des cellules en suspension. En outre, l'invention concerne un vaccin préventif contre la fièvre catarrhale du mouton ou une infection causée par le sérotype 12 du virus de la fièvre catarrhale du mouton (BTV-12) chez des ruminants. L'invention concerne également des procédés d'inactivation du virus de la fièvre catarrhale du mouton.
PCT/IN2014/000204 2013-03-31 2014-04-01 Composition de vaccin contre la prophylaxie chez des ruminants Ceased WO2014167582A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1268CH2013 2013-03-31
IN1268/CHE/2013 2013-03-31

Publications (2)

Publication Number Publication Date
WO2014167582A2 WO2014167582A2 (fr) 2014-10-16
WO2014167582A3 true WO2014167582A3 (fr) 2014-12-24

Family

ID=51690090

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2014/000204 Ceased WO2014167582A2 (fr) 2013-03-31 2014-04-01 Composition de vaccin contre la prophylaxie chez des ruminants

Country Status (1)

Country Link
WO (1) WO2014167582A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3186367A4 (fr) * 2014-08-29 2018-01-24 Biovet Private Limited Vaccin contre le virus de la fièvre catarrhale et ses procédés de fabrication
JP7432506B2 (ja) 2017-10-30 2024-02-16 武田薬品工業株式会社 脂質エンベロープウイルスを不活化するための環境適合性の界面活性剤
CN109200282A (zh) * 2018-11-23 2019-01-15 中国兽医药品监察所 一种羊痘灭活疫苗及其生产方法
CN112870346A (zh) * 2021-01-21 2021-06-01 云南省畜牧兽医科学院 一种蓝舌病病毒二价灭活疫苗的制备方法
CN119039427B (zh) * 2024-08-12 2025-03-25 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) 一株绵羊抗蓝舌病毒的重组单个b细胞抗体

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009065930A1 (fr) * 2007-11-21 2009-05-28 Wyeth Farma, S.A. Compositions immunogènes et de vaccin du virus de la fièvre catarrhale du mouton, leurs procédés d'utilisation et leurs procédés de fabrication
WO2009128043A1 (fr) * 2008-04-16 2009-10-22 Onderstepoort Biological Products Ltd Vaccin contre le virus vivant atténué inactivé de la fièvre catarrhale ovine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009065930A1 (fr) * 2007-11-21 2009-05-28 Wyeth Farma, S.A. Compositions immunogènes et de vaccin du virus de la fièvre catarrhale du mouton, leurs procédés d'utilisation et leurs procédés de fabrication
WO2009128043A1 (fr) * 2008-04-16 2009-10-22 Onderstepoort Biological Products Ltd Vaccin contre le virus vivant atténué inactivé de la fièvre catarrhale ovine

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
BROWN ET AL.: "The Effect of Various Inactivating Agents on the Viral and Ribonucleic Acid Infectivities of Foot-and-Mouth Disease Virus and on its Attachment to Susceptible Cells", J . GEN. MICROBIAL., vol. 31, 1963, pages 179 - 186 *
HATA ATSUKO ET AL.: "Use of an inactivated varicella vaccine in recipients of hematopoieticcell transplants.", THE NEW ENGLAND JOURNAL OF MEDICINE, vol. 347, no. 1, 4 July 2002 (2002-07-04), pages 26 - 34 *
MARTIN JAVIER ET AL.: "Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains", JOURNAL OF GENERAL VIROLOGY, SOCIETY FOR. GENERAL MICROBIOLOGY, vol. 84, no. 7, 1 July 2003 (2003-07-01), GB, pages 1781 - 1788 *
MATTION N ET AL.: "Reintroduction of foot-and-mouth disease in Argentina : characterisation of the isolates and development of tools for the control and eradication of the disease", VACCINE, vol. 22, no. 31-32, 22 October 2004 (2004-10-22), GUILDFORD, GB, pages 4149 - 4162 *
NARENDER S. MAAN ET AL.: "Identification and Differentiation of the Twenty Six Bluetongue Virus Serotypes by RT-PCR Amplification of the Serotype-Specific Genome Segment 2", PLOS ONE, vol. 7, no. 2, 28 February 2012 (2012-02-28), pages 1 - 9 *
ODEON A C ET AL.: "The role of cell -mediated immunity in the pathogenesis of bluetongue virus serotype 11 in the experimental infection of vaccine/sensitized calves.", COMPARATIVE IMMUNOLOGY, MICROBIOLOGY AND INFECTIOUS DISEASES JUN 1997, vol. 20, no. 3, June 1997 (1997-06-01), pages 219 - 231 *
RAMAKRISHNAN M A ET AL.: "Immune Responses and Protective Efficacy of Binary Ethylenimine (BEI)-Inactivated Bluetongue Virus Vaccines in Sheep", VETERINARY RESEARCH COMMUNICATIONS ; AN INTERNATIONAL JOURNAL PUBLISHING TOPICAL REVIEWS AND RESEARCH ARTICLES ON ALL ASPECTS OF THE VETERINARY SCIENCES, vol. 30, no. 8, 1 November 2006 (2006-11-01), pages 873 - 880 *
SAVIN I G ET AL.: "An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy .", VETERINARY MICROBIOLOGY, vol. 124, no. 1-2, 20 September 2007 (2007-09-20), pages 140 - 146 *
SAVINI ET AL.: "Vaccines against bluetongue in Europe", COMPARATIVE IMMUNOLOGY, MICROBIOLOGY AND INFECTIOUS DISEASES, vol. 31, no. 2-3, 1 March 2008 (2008-03-01), OXFORD, GB, pages 101 - 120 *

Also Published As

Publication number Publication date
WO2014167582A2 (fr) 2014-10-16

Similar Documents

Publication Publication Date Title
WO2016019134A8 (fr) Agents à base de flagelline et utilisations comportant une vaccination efficace
WO2017100726A8 (fr) Méthodes de traitement de la maladie de huntington
WO2017070616A3 (fr) Vaccins contre les maladies sexuellement transmissibles
WO2017070626A3 (fr) Vaccins contre les virus respiratoires
MX2021011906A (es) Composiciones de liberacion retardada de linaclotida.
WO2011103453A3 (fr) Vaccins destinés à être utilisés pour la prophylaxie et le traitement d'une maladie liée au virus de la grippe
WO2014158811A8 (fr) Virus de la maladie de newcastle et leurs utilisations
IN2015DN03327A (fr)
WO2014180889A8 (fr) Méthodes et compositions destinées à traiter le cancer
WO2011160024A3 (fr) Composés utiles en tant qu'agents antiviraux, compositions, et procédés d'utilisation
HK1248069A1 (zh) 去乙酰氧基微管溶素h及其类似物
MY197723A (en) Vaccine compositions for the prevention of dengue virus infection
PH12016501968A1 (en) Novel macrocyclic compounds
MY189495A (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
EP4241851A3 (fr) Compositions immunogenes
MX2013012233A (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas sustituidas.
UA115357C2 (uk) Похідні піридин-4-ілу
MX2015017011A (es) Compuestos nuevos para el tratamiento del cancer.
WO2016100615A3 (fr) Procédés et composition pour la neutralisation de la grippe
EP3057611A4 (fr) Compositions de vaccins thermostables contre le virus respiratoire syncytial (rsv)
MX2015000179A (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
WO2016119052A8 (fr) Compositions et méthodes d'amélioration de l'efficacité d'un virus oncolytique
WO2016141320A3 (fr) Virus non neuro-invasifs et leurs utilisations
WO2014133811A3 (fr) Composés dérivés de plantes salvinia invasives et leurs procédés d'utilisation
MY171497A (en) Crystalline forms of dihydropyrimidine derivatives

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 14783518

Country of ref document: EP

Kind code of ref document: A2